These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25519477)

  • 21. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.
    de Albuquerque A; Kubisch I; Stölzel U; Ernst D; Boese-Landgraf J; Breier G; Stamminger G; Fersis N; Kaul S
    J Transl Med; 2012 Nov; 10():222. PubMed ID: 23146106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.
    Bork U; Rahbari NN; Schölch S; Reissfelder C; Kahlert C; Büchler MW; Weitz J; Koch M
    Br J Cancer; 2015 Apr; 112(8):1306-13. PubMed ID: 25867263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
    Wang S; Liu X; Lv H; Yu J; Li H
    J Evid Based Med; 2024 Jun; 17(2):329-340. PubMed ID: 38600712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer.
    Lu YJ; Wang P; Peng J; Wang X; Zhu YW; Shen N
    Sci Rep; 2017 Apr; 7(1):905. PubMed ID: 28424486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy.
    Thalgott M; Heck MM; Eiber M; Souvatzoglou M; Hatzichristodoulou G; Kehl V; Krause BJ; Rack B; Retz M; Gschwend JE; Andergassen U; Nawroth R
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1457-64. PubMed ID: 25708944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells count predicts survival in colorectal cancer patients.
    Romiti A; Raffa S; Di Rocco R; Roberto M; Milano A; Zullo A; Leone L; Ranieri D; Mazzetta F; Medda E; Sarcina I; Barucca V; D'Antonio C; Durante V; Ferri M; Torrisi MR; Marchetti P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):279-84. PubMed ID: 25267956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer.
    Okegawa T; Itaya N; Hara H; Tambo M; Nutahara K
    Anticancer Res; 2014 Nov; 34(11):6705-10. PubMed ID: 25368278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
    Fan JL; Yang YF; Yuan CH; Chen H; Wang FB
    Cell Physiol Biochem; 2015; 37(2):629-40. PubMed ID: 26344495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of circulating tumor cells in esophageal cancer.
    Xu HT; Miao J; Liu JW; Zhang LG; Zhang QG
    World J Gastroenterol; 2017 Feb; 23(7):1310-1318. PubMed ID: 28275311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
    Musella V; Pietrantonio F; Di Buduo E; Iacovelli R; Martinetti A; Sottotetti E; Bossi I; Maggi C; Di Bartolomeo M; de Braud F; Daidone MG; Cappelletti V
    Int J Cancer; 2015 Sep; 137(6):1467-74. PubMed ID: 25704501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
    Lu G; Lu Z; Li C; Huang X; Luo Q
    Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
    Li Y; Wu G; Yang W; Wang X; Duan L; Niu L; Zhang Y; Liu J; Hong L; Fan D
    BMC Cancer; 2020 Jun; 20(1):581. PubMed ID: 32571299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
    Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
    BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
    Jiang H; Gu X; Zuo Z; Tian G; Liu J
    PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
    Bidard FC; Michiels S; Riethdorf S; Mueller V; Esserman LJ; Lucci A; Naume B; Horiguchi J; Gisbert-Criado R; Sleijfer S; Toi M; Garcia-Saenz JA; Hartkopf A; Generali D; Rothé F; Smerage J; Muinelo-Romay L; Stebbing J; Viens P; Magbanua MJM; Hall CS; Engebraaten O; Takata D; Vidal-Martínez J; Onstenk W; Fujisawa N; Diaz-Rubio E; Taran FA; Cappelletti MR; Ignatiadis M; Proudhon C; Wolf DM; Bauldry JB; Borgen E; Nagaoka R; Carañana V; Kraan J; Maestro M; Brucker SY; Weber K; Reyal F; Amara D; Karhade MG; Mathiesen RR; Tokiniwa H; Llombart-Cussac A; Meddis A; Blanche P; d'Hollander K; Cottu P; Park JW; Loibl S; Latouche A; Pierga JY; Pantel K
    J Natl Cancer Inst; 2018 Jun; 110(6):560-567. PubMed ID: 29659933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.
    Chou WC; Wu MH; Chang PH; Hsu HC; Chang GJ; Huang WK; Wu CE; Hsieh JC
    Int J Biol Sci; 2018; 14(2):137-146. PubMed ID: 29483832
    [No Abstract]   [Full Text] [Related]  

  • 40. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.